Share this page:
Date | Title |
---|---|
Jun 18, 2020
|
Source
FierceBiotech
|
Apr 7, 2020
|
Source
Pharmaceutical Technology
|
Apr 6, 2020
|
Source
BioPharma Dive
|
Apr 6, 2020
|
Source
STAT
|
Apr 6, 2020
|
Source
FierceBiotech
|
Apr 6, 2020
|
Source
Endpoints
|
Apr 6, 2020
|
Source
Boston Business Journal
|
Jan 11, 2020
|
Source
PharmaVOICE
By
Denise Myshko
|
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.